Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 3 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Jemperli contends with blockbuster Keytruda in endometrial cancer
Clinical Trials Arena via Yahoo Finance· 4 days agoThe sBLA approval is based on the success of the Phase III RUBY Part I trial and places Jemperli in...
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
Morningstar· 5 days ago- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies - SITC 2023 Presentation of the Phase ...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 3 days agoMerck (MSD) has announced the final analysis findings from the Phase III KEYNOTE-811 clinical trial...
Is Merck Stock Fully Valued At $130?
Forbes· 4 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News
MedPage Today· 2 days agoNews, features, and commentary about cancer-related issues
3 Investing Pros Lay Out Their Dividend Strategies—and Stock Picks
Barrons.com· 3 days agoIn February, Walmart announced a 9% dividend increase, its largest in more than a decade. Another of...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 3 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...